Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$28.64+0.02 (+0.07%)
Close on Nov 13, 2026Market cap $1.71BP/E –Yield –
Kestra Medical Technologies EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Kestra Medical Technologies's EPS for the twelve months ending Jul 31, 2026 was -$2.67. For fiscal 2026 it was -$2.43.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -$2.43 | – |
| FY2025 | Apr 30, 2025 | -$5.13 | – |
| FY2024 | Apr 30, 2024 | -$5.07 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -$0.75 | – |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | -$0.67 | – |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | -$0.61 | – |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | -$0.64 | – |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -$0.50 | – |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | -$1.43 | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | -$1.25 | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | -$1.19 | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -$1.12 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?